Articles
Page 5 of 82
-
Citation: Orphanet Journal of Rare Diseases 2023 18:318
-
The patients’ organisations of children with primary immunodeficiency in Poland
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P24 -
Advances in muscle imaging for Emery-Dreifuss muscular dystrophy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O26 -
Clinical aspects of cardiolaminopathies and prospects for a cardiolaminopathy registry
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O30 -
Five novel TTR variants: associated phenotypes and structural consequences
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P28 -
Prevalence, risk factors and correlation with cardiac involvement of carpal tunnel syndrome in amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P32 -
Determinants for research on rare diseases
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O16 -
Correction: Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022
Citation: Orphanet Journal of Rare Diseases 2023 18:370 -
Comparative demographics of the European Cystic Fibrosis population: does EU membership confer an advantage?
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O20 -
The Italian project to increase health professionals’ training and awareness on rare diseases
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A16 -
Empowerment Weekends for young adults
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O35 -
Correction to: Phenotype, genotype and long-term prognosis of 40 Chinese patients with isobutyryl-CoA dehydrogenase deficiency and a review of variant spectra in ACAD8
Citation: Orphanet Journal of Rare Diseases 2021 16:505 -
Towards a European platform for Rare Diseases Registries
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O6 -
Diflunisal in late-onset FAP patients with moderate to severe neuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O24 -
Biopsy experience in a FAP endemic area
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I15 -
Prenatal therapy in developmental disorders: drug targeting via intra-amniotic injection to treat X-linked hypohidrotic ectodermal dysplasia
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):P10 -
Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P1 -
Evaluation of population newborn screening practices for rare disorders in member states of the European Union
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P26 -
The German plan for rare diseases: a development in progress
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O1 -
Round Table: Discussion with families and lay associations
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O28 -
Correction to: Clinical features and treatment efficacy for IgG4-related thyroiditis
Citation: Orphanet Journal of Rare Diseases 2021 16:459 -
ECLip-the European consortium on lipodystrophies: an update
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O32 -
Usefulness of combining electrocardiogram and echocardiography findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P34 -
Predictors of orphan drug approval
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O18 -
Scope and management of Patient Registries for orphan rare disease (ORD) meeting the demands of all involved stakeholders
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O22 -
Spina Bifida and primary prevention
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A18 -
Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development
Citation: Orphanet Journal of Rare Diseases 2024 19:131 -
EPIRARE survey on activities and needs of rare disease registries in the European Union
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A22 -
Correction: Estimating mortality in rare diseases using a population-based registry, 2002 through 2019
Citation: Orphanet Journal of Rare Diseases 2024 19:43 -
State of the art of rare disease activities in Europe: a EUCERD perspective
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A1 -
National Rare Disease Registries: overview from Spain
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):O8 -
Quality of life in ATTR amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O26 -
Setting up strategies: patient inclusion in biobank and genomics research in Europe
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):P2 -
Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
Citation: Orphanet Journal of Rare Diseases 2023 18:29 -
Minimal assessment of the index case: the point of view of the cardiologist
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I21 -
E-learning course for Norwegian caregivers
Citation: Orphanet Journal of Rare Diseases 2014 9(Suppl 1):P12 -
Correction: Qualitative analysis of patient interviews on the burden of neuronopathic Gaucher disease in Japan
Citation: Orphanet Journal of Rare Diseases 2023 18:67 -
Wild-type transthyretin amyloidosis in female patients
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O9 -
The role of complement in ATTR amyloidosis: a new therapeutic avenue?
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P3 -
Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I1 -
Issues of management of Epidermolysis bullosa in Georgia
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):P28 -
Recommendations for the development of national plans for rare diseases
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O3 -
Applications of the PMO platform to genetic diseases
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 2):O34 -
Delayed small bowel octreotide response in patients with hereditary transthyretin amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P36 -
MR-Neurography of the sural nerve in patients with hereditary amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P40 -
EMP's first steps in the field of clinical trials
Citation: Orphanet Journal of Rare Diseases 2010 5(Suppl 1):O24 -
Correction to: Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing
Citation: Orphanet Journal of Rare Diseases 2022 17:427 -
National plans: case study Belgium
Citation: Orphanet Journal of Rare Diseases 2012 7(Suppl 2):A3 -
Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O28 -
TTR amyloidosis: a scientific journey since Andrade
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I19
Follow
- ISSN: 1750-1172 (electronic)